# OnCo record paper-uspstf-prostate-screening-jama-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-uspstf-prostate-screening-jama-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-uspstf-prostate-screening-jama-2018" ;
  schema:name "USPSTF 2018: screening for prostate cancer, recommendation statement (grade C at 55 to 69, grade D at 70 and over)"@en ;
  schema:alternateName "USPSTF 2018 prostate"@en, "grade C prostate screening"@en, "shared decision making prostate screening"@en ;
  schema:description "Six years after recommending against PSA testing for everyone, the same body changed its mind for men aged 55 to 69 and said the decision should be theirs. The statement puts the numbers on both sides: about 1.3 deaths prevented per 1,000 men screened, and one in five who have surgery left with long-term incontinence."@en ;
  schema:url <https://onco.cc/key-papers/paper-uspstf-prostate-screening-jama-2018/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2018.3710>, <https://pubmed.ncbi.nlm.nih.gov/29801017/>, <https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening> ;
  onco:tag "prostate-evidence" ;
  schema:sameAs <https://doi.org/10.1001/jama.2018.3710> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "US Preventive Services Task Force, Grossman DC, Curry SJ, et al." ;
  onco:related <https://onco.cc/key-papers/paper-moyer-uspstf-prostate-screening-ann-intern-med-2012/>, <https://onco.cc/key-papers/paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014/>, <https://onco.cc/key-papers/paper-protect-15-year-nejm-2023/>, <https://onco.cc/ideas/idea-acc-embedded-decision-aids/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/prevention/> ;
  onco:terms <https://onco.cc/terms/psa/>, <https://onco.cc/terms/screening/>, <https://onco.cc/terms/overdiagnosis/>, <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/terms/overtreatment/>, <https://onco.cc/terms/number-needed-to-screen/>, <https://onco.cc/terms/other-cause-mortality/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-patient-voice/>, <https://onco.cc/bottlenecks/b-trial-diversity/> ;
  onco:journals <https://onco.cc/journals/jama/> .